vs
安朗杰（ALLE）与Cooper Companies (The)（COO）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是安朗杰的1.0倍（$1.1B vs $1.0B），安朗杰净利率更高（13.4% vs 7.9%，领先5.4%），安朗杰同比增速更快（9.7% vs 4.6%），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 3.5%）
安朗杰是全球知名的安防产品及解决方案供应商，面向全球生产销售机械与电子类安防产品，包括闭门器、出入口控制设备、锁具、电子门禁系统、考勤与人员效能管理系统、门体系统及相关配件，服务商业、公共机构、住宅等多领域终端用户
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
ALLE vs COO — 直观对比
营收规模更大
COO
是对方的1.0倍
$1.0B
营收增速更快
ALLE
高出5.2%
4.6%
净利率更高
ALLE
高出5.4%
7.9%
两年增速更快
COO
近两年复合增速
3.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.1B |
| 净利润 | $138.1M | $84.6M |
| 毛利率 | 44.0% | 61.1% |
| 营业利润率 | 18.9% | 13.2% |
| 净利率 | 13.4% | 7.9% |
| 营收同比 | 9.7% | 4.6% |
| 净利润同比 | -6.8% | -28.0% |
| 每股收益（稀释后） | — | $0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLECOO
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $941.9M | $964.7M | ||
| Q4 24 | $945.6M | $1.0B | ||
| Q3 24 | $967.1M | $1.0B | ||
| Q2 24 | $965.6M | $942.6M |
净利润ALLECOO
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $84.6M | ||
| Q3 25 | $188.4M | $98.3M | ||
| Q2 25 | $159.7M | $87.7M | ||
| Q1 25 | $148.2M | $104.3M | ||
| Q4 24 | $144.1M | $117.5M | ||
| Q3 24 | $174.2M | $104.7M | ||
| Q2 24 | $155.4M | $88.9M |
毛利率ALLECOO
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | 61.1% | ||
| Q3 25 | 45.8% | 65.3% | ||
| Q2 25 | 45.6% | 67.8% | ||
| Q1 25 | 44.9% | 68.4% | ||
| Q4 24 | 44.1% | 66.5% | ||
| Q3 24 | 44.7% | 66.1% | ||
| Q2 24 | 44.4% | 67.0% |
营业利润率ALLECOO
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | 13.2% | ||
| Q3 25 | 21.8% | 16.6% | ||
| Q2 25 | 21.5% | 18.4% | ||
| Q1 25 | 20.9% | 18.9% | ||
| Q4 24 | 19.5% | 19.5% | ||
| Q3 24 | 22.2% | 19.2% | ||
| Q2 24 | 21.6% | 17.2% |
净利率ALLECOO
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | 7.9% | ||
| Q3 25 | 17.6% | 9.3% | ||
| Q2 25 | 15.6% | 8.7% | ||
| Q1 25 | 15.7% | 10.8% | ||
| Q4 24 | 15.2% | 11.5% | ||
| Q3 24 | 18.0% | 10.4% | ||
| Q2 24 | 16.1% | 9.4% |
每股收益（稀释后）ALLECOO
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $0.42 | ||
| Q3 25 | $2.18 | $0.49 | ||
| Q2 25 | $1.85 | $0.44 | ||
| Q1 25 | $1.71 | $0.52 | ||
| Q4 24 | $1.65 | $0.59 | ||
| Q3 24 | $1.99 | $0.52 | ||
| Q2 24 | $1.77 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $308.9M | $110.6M |
| 总债务越低越好 | $2.0B | $2.5B |
| 股东权益账面价值 | $2.1B | $8.2B |
| 总资产 | $5.3B | $12.4B |
| 负债/权益比越低杠杆越低 | 0.97× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ALLECOO
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $110.6M | ||
| Q3 25 | $302.7M | $124.9M | ||
| Q2 25 | $656.8M | $116.2M | ||
| Q1 25 | $494.5M | $100.9M | ||
| Q4 24 | $503.8M | $107.6M | ||
| Q3 24 | $878.9M | $109.7M | ||
| Q2 24 | $747.5M | $112.4M |
总债务ALLECOO
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.5B | ||
| Q3 25 | $2.1B | $2.4B | ||
| Q2 25 | $2.1B | $2.5B | ||
| Q1 25 | $2.0B | $2.5B | ||
| Q4 24 | $2.0B | $2.6B | ||
| Q3 24 | $2.4B | $2.6B | ||
| Q2 24 | $2.4B | $2.7B |
股东权益ALLECOO
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $8.2B | ||
| Q3 25 | $1.9B | $8.4B | ||
| Q2 25 | $1.8B | $8.3B | ||
| Q1 25 | $1.6B | $8.1B | ||
| Q4 24 | $1.5B | $8.1B | ||
| Q3 24 | $1.6B | $7.9B | ||
| Q2 24 | $1.4B | $7.8B |
总资产ALLECOO
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $12.4B | ||
| Q3 25 | $5.2B | $12.4B | ||
| Q2 25 | $4.9B | $12.4B | ||
| Q1 25 | $4.6B | $12.2B | ||
| Q4 24 | $4.5B | $12.3B | ||
| Q3 24 | $5.0B | $12.1B | ||
| Q2 24 | $4.8B | $12.0B |
负债/权益比ALLECOO
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 0.30× | ||
| Q3 25 | 1.07× | 0.29× | ||
| Q2 25 | 1.16× | 0.30× | ||
| Q1 25 | 1.24× | 0.31× | ||
| Q4 24 | 1.33× | 0.32× | ||
| Q3 24 | 1.53× | 0.33× | ||
| Q2 24 | 1.69× | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $101.3M | $247.9M |
| 自由现金流经营现金流 - 资本支出 | — | $149.9M |
| 自由现金流率自由现金流/营收 | — | 14.1% |
| 资本支出强度资本支出/营收 | 2.0% | 9.2% |
| 现金转化率经营现金流/净利润 | 0.73× | 2.93× |
| 过去12个月自由现金流最近4个季度 | — | $433.7M |
8季度趋势，按日历期对齐
经营现金流ALLECOO
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $247.9M | ||
| Q3 25 | $229.5M | $261.4M | ||
| Q2 25 | $209.7M | $96.2M | ||
| Q1 25 | $104.5M | $190.6M | ||
| Q4 24 | $219.0M | $268.1M | ||
| Q3 24 | $231.9M | $207.5M | ||
| Q2 24 | $173.0M | $111.0M |
自由现金流ALLECOO
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $149.9M | ||
| Q3 25 | $209.8M | $164.5M | ||
| Q2 25 | $192.0M | $18.1M | ||
| Q1 25 | $83.4M | $101.2M | ||
| Q4 24 | $194.9M | $128.1M | ||
| Q3 24 | $212.0M | $118.5M | ||
| Q2 24 | $152.1M | $36.9M |
自由现金流率ALLECOO
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 14.1% | ||
| Q3 25 | 19.6% | 15.5% | ||
| Q2 25 | 18.8% | 1.8% | ||
| Q1 25 | 8.9% | 10.5% | ||
| Q4 24 | 20.6% | 12.6% | ||
| Q3 24 | 21.9% | 11.8% | ||
| Q2 24 | 15.8% | 3.9% |
资本支出强度ALLECOO
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 9.2% | ||
| Q3 25 | 1.8% | 9.1% | ||
| Q2 25 | 1.7% | 7.8% | ||
| Q1 25 | 2.2% | 9.3% | ||
| Q4 24 | 2.5% | 13.7% | ||
| Q3 24 | 2.1% | 8.9% | ||
| Q2 24 | 2.2% | 7.9% |
现金转化率ALLECOO
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | 2.93× | ||
| Q3 25 | 1.22× | 2.66× | ||
| Q2 25 | 1.31× | 1.10× | ||
| Q1 25 | 0.71× | 1.83× | ||
| Q4 24 | 1.52× | 2.28× | ||
| Q3 24 | 1.33× | 1.98× | ||
| Q2 24 | 1.11× | 1.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
